2021 annual financial data
Allogene Therapeutics, Inc. - Common Stock 2021 Operating margin
Allogene Therapeutics, Inc. - Common Stock 2021 operating margin with verified…
Direct answer
Operating margin was -664.58%.
Operating income was -255,792,000 USD and net income was -244,837,000 USD.
Operating cash flow was -184,812,000 USD.
Verified data
- Revenue
- 38,489,000 USD
- Operating income
- -255,792,000 USD
- Net income
- -244,837,000 USD
- Operating cash flow
- -184,812,000 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Allogene Therapeutics, Inc. - Common Stock financial years